Investor profile
Sofinnova Capital X
Sofinnova Partners SAS · Multi-Country
Investment focus
Start with the fit.
Sofinnova Capital X is a life sciences venture fund managed by Sofinnova Partners, the Paris-based firm founded in 1972. It backs early-stage biopharmaceutical and medical technology companies across Europe and North America, participating in both initial and follow-on rounds.
EUACC Intelligence
Free preview
EUACC Intelligence
Research Sofinnova Capital X
Explore the record and prepare questions for the fund.
Your side of the introduction
List your startup →